SE7609339L - Farmaceutiska bassalter - Google Patents

Farmaceutiska bassalter

Info

Publication number
SE7609339L
SE7609339L SE7609339A SE7609339A SE7609339L SE 7609339 L SE7609339 L SE 7609339L SE 7609339 A SE7609339 A SE 7609339A SE 7609339 A SE7609339 A SE 7609339A SE 7609339 L SE7609339 L SE 7609339L
Authority
SE
Sweden
Prior art keywords
base salts
pharmaceutical base
pharmaceutical
salts
base
Prior art date
Application number
SE7609339A
Other languages
English (en)
Inventor
I Blank
J Fertig
Original Assignee
Hydrophilics Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3529575A external-priority patent/GB1563390A/en
Application filed by Hydrophilics Int Inc filed Critical Hydrophilics Int Inc
Publication of SE7609339L publication Critical patent/SE7609339L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
SE7609339A 1975-08-27 1976-08-23 Farmaceutiska bassalter SE7609339L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3529575A GB1563390A (en) 1975-08-27 1975-08-27 Pharmaceutical products
GB3529675 1975-08-27
GB2396276 1976-06-10
GB2396376 1976-06-10

Publications (1)

Publication Number Publication Date
SE7609339L true SE7609339L (sv) 1977-02-28

Family

ID=27448608

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609339A SE7609339L (sv) 1975-08-27 1976-08-23 Farmaceutiska bassalter

Country Status (5)

Country Link
JP (1) JPS5254014A (sv)
CH (1) CH621940A5 (sv)
DE (1) DE2636559C2 (sv)
IL (1) IL50250A (sv)
SE (1) SE7609339L (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
HU187313B (en) * 1980-10-03 1985-12-28 Andras Sugar Dental cosmetic prparation
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
EP0103970A3 (en) * 1982-08-20 1985-05-22 LAWRENCE, Peter Robin Broughton Amine salts and products containing them
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
WO1987007154A1 (en) * 1986-05-29 1987-12-03 Vsesojuzny Nauchno-Issledovatelsky I Ispytatelny I Antitumor film of biodestructible polymers
DE19549506C2 (de) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
JP2001503041A (ja) * 1996-10-23 2001-03-06 エスケーダヴリュ トロストベルグ アクチエンゲゼルシャフト 生物活性ポリマーナノ粒子―核酸接合体の製造方法
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DK172900B1 (da) * 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
MY183421A (en) * 2011-03-18 2021-02-18 Seed Co Ltd Medical device for controlled release of drug
JP2017080303A (ja) * 2015-10-30 2017-05-18 日油株式会社 薬物徐放性医療用コンタクトレンズ
CA3081553C (en) 2017-11-17 2022-11-15 Cellix Bio Private Limited Compositions and methods for the treatment of eye disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229984A1 (de) * 1972-06-20 1974-01-10 Kraemer Kg Wilhelm Befestigungsvorrichtung fuer eine batteriegespeiste warnleuchte
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform

Also Published As

Publication number Publication date
DE2636559A1 (de) 1977-03-17
CH621940A5 (en) 1981-03-13
JPS5254014A (en) 1977-05-02
IL50250A0 (en) 1976-10-31
IL50250A (en) 1980-01-31
DE2636559C2 (de) 1985-10-31

Similar Documents

Publication Publication Date Title
DK533476A (da) Kapsler
BE840307A (fr) Carbodimides
DK115376A (da) Kinolonderivater
BR7600226A (pt) Conjunto de medicao
SE7601274L (sv) Isoxazolylbensamid-derivat
SE7609339L (sv) Farmaceutiska bassalter
AT350119B (de) Zeitbasis-ausgleichkreis
DK116576A (da) Salicylanilidderivater
SE7505163L (sv) Torneschoke for hagelvapen
NO146045C (no) Oralt roentgenkontrastmiddel for cholecystangiografi
SE408266B (sv) Narkosmedelavdunstare
SE416860B (sv) Plan radarantenn
SE408126B (sv) Berband for blixtlas
SE7608478L (sv) Farmaceutica
SE414700B (sv) Artikulator
SE423038B (sv) Narkosmedelsforangare med shuntstrom
SE7609476L (sv) Berkonstruktion for bergtunnlar
FI773812A (fi) Farmaceutiska foereningar
SE411166B (sv) Berband for blixtlas
FR2318781A1 (fr) Bollard
FI65878B (fi) Vertikal avboejningskrets
SE7613797L (sv) Cyproheptadinderivat
FR2301854A1 (fr) Dis
FI773813A (fi) Farmaceutiska foereningar
RO75865A (ro) Unicare consistenta